Exchange: NASDAQ·Updated 07:59 PM EST
OVID logo

OVID Ovid Therapeutics Inc

$2.20
$0.14
(5.98%)
Today
Closed $2.20
$0.0984
(4.47%)
After Hours
Reported EarningsNov 10
Mkt Cap$415.21M
Vol2.83M

About OVID

Ovid Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering better, gentler medicines for the brain. It discovers and develops differentiated, small molecule medicines for neurological and neuropsychiatric disorders with significant unmet need. The company was founded by Matthew During and Jeremy M. Levin on April 1, 2014 and is headquartered in New York, NY.
46

Neutral Sentiment

How do you feel about OVID?

michaelhearn
$OVID institutions own 85%. St investors 7%. Hold your shares tightly. This should rocket soon. 6 low end
1
signaljumper
$OVID 2 Main resistance left 2.07 and 2.10 If WE can Break this Level in the coming days rhen WE have space to Run 3.39, 3.65 and 3.97 this are the next 3 Targets If WE can Break 3.10
1
signaljumper
$OVID If WE can Break 3.07 then we will See a bigger runup and we triggera bullish buy Signal for the next Leg Up (Wave)
1
michaelhearn
$OVID keeping track of buying. It’s now over 90% gobbled up. Hold your shares toght. But a $6 sell limit. Won’t be long now
focafoca99
$OVID reveals its Q3 2026 financial results and business updates in a press release filed with the SEC.
StocktwitsEarnings
$OVID Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.10 up 41.18% YoY • Reported revenue of $0M

Advertisement|Remove ads.